메뉴 건너뛰기




Volumn 142, Issue 5, 2001, Pages 745-747

Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CORONARY ARTERY DISEASE; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; METHODOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034748580     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.119135     Document Type: Article
Times cited : (24)

References (14)
  • 6
    • 0033546967 scopus 로고    scopus 로고
    • Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial
    • ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison
    • (1999) Lancet , vol.354 , pp. 885-890
    • Burkhoff, D.1    Schmidt, S.2    Schulman, S.P.3
  • 9
    • 0027368467 scopus 로고
    • Users' guides to the medical literature, II: How to use an article about therapy or prevention. A. Are the results of the study valid?
    • Evidence-Based Medicine Working Group
    • (1993) JAMA , vol.270 , pp. 2598-2601
    • Guyatt, G.H.1    Sackett, D.L.2    Cook, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.